🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
29.96
-1.48 (-4.71%)
At close: Nov 20, 2026, 4:00 PM EST
30.20
+0.24 (0.80%)
After-hours: Nov 20, 2026, 5:33 PM EST

Viridian Therapeutics Stock Forecast

Stock Price Forecast

According to 18 analysts polled by S&P Global, Viridian Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $42.76. The average 1-year stock price forecast is 42.72% higher than the current stock price, while the lowest is $33 (+10.15%) and the highest is $54 (+80.24%).

Price Target: $42.76 (+42.72%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$33$42.76$42$54
Change+10.15%+42.72%+40.19%+80.24%

Analyst Ratings

The average analyst rating for Viridian Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy141414141415
Buy333333
Hold000000
Sell000000
Strong Sell000000
Total171717171718

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Bank of America Securities
Bank of America Securities
Buy
Initiates
$47
BuyInitiates$47+56.88%Nov 19, 2026
Wells Fargo
Wells Fargo
Buy
Reiterates
$34 → $39
BuyReiterates$34 → $39+30.17%Nov 10, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Maintains
$40
BuyMaintains$40+33.51%Nov 9, 2026
Unknown Analyst
Leerink Partners
No rating
Leerink Partners
Buy
Reiterates
$50 → $54
BuyReiterates$50 → $54+80.24%Nov 5, 2026
Evercore ISI
Evercore ISI
Buy
Maintains
$26 → $33
BuyMaintains$26 → $33+10.15%Nov 5, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
76.22M
from 70.85M
Increased by 7.57%
Revenue Next Year
323.39M
from 76.22M
Increased by 324.31%
EPS This Year
-3.48
from -3.32
EPS Next Year
-2.07
from -3.48
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026E
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
2.96M1.77M314.00K302.00K70.85M76.22M
Revenue Growth
182.19%-40.20%-82.28%-3.82%23,359.93%7.57%
Operating Income
-79.73M-134.30M-254.45M-299.04M-363.40M-434.95M
Net Income
-79.41M-129.87M-237.73M-269.95M-342.60M-414.76M
EPS
-----3.32-3.48
Free Cash Flow
-----329.51M-358.50M
No. Analysts
-----15
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High97.5M
Avg76.2M
Low55.9M

Revenue Growth

Revenue Growth202620272028
High
37.6%
Avg
7.6%
Low
-21.1%

EPS Forecast

EPS202620272028
High-2.81
Avg-3.48
Low-3.98

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-